KYNB's three largest insider shareholders as of August 04, 2026 are Enrique A Conterno (Chief Executive Officer, 374.72K shares), Christine Chung (Svp, China Operations, 294.90K shares), Pat Cotroneo (Executive Advisor Former Cfo, 274.54K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Thomas F Jr Kearns | - | 39,764 | 0 | 17 Sep, 2021 |
| Jeffrey L Edwards | - | 33,977 | 0 | 09 Jun, 2023 |
| Jeffrey William Henderson | - | 28,866 | 0 | 06 Sep, 2023 |
| James A Schoeneck | - | 0 | 39,666 | 02 Jul, 2025 |
| Enrique A Conterno | Chief Executive Officer | 374,722 | 0 | 10 Jul, 2023 |
| Pat Cotroneo | Executive Advisor Former Cfo | 274,536 | 0 | 09 Sep, 2021 |
| Maykin Ho | - | 31,501 | 0 | 09 Jun, 2023 |
| Aoife Brennan | - | 27,947 | 0 | 09 Jun, 2023 |
| Gerald Lema | - | 28,766 | 0 | 09 Jun, 2023 |
| Christine Chung | Svp, China Operations | 294,903 | 0 | 07 Mar, 2025 |
| Suzanne Blaug | - | 29,594 | 0 | 09 Jun, 2023 |
| Thane Wettig | Chief Commercial Officer | 109,889 | 0 | 10 Mar, 2023 |
| Benjamin Cravatt | - | 28,736 | 0 | 09 Jun, 2023 |
| Mark Eisner | Evp, Chief Medical Officer | 159,917 | 0 | 08 Sep, 2023 |
| Juan Graham | Chief Financial Officer | 164,863 | 0 | 09 Dec, 2024 |
| Deyaa Adib | Chief Medical Officer | 82,123 | 0 | 13 Jun, 2024 |
| David Delucia | Chief Financial Officer | 4,429 | 0 | 10 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 06 Mar, 2026 | Thane Wettig | Common Stock | D | 277 | $6.84 | 24,403 | D | F |
| 06 Mar, 2026 | David Delucia | Common Stock | D | 60 | $6.84 | 4,429 | D | F |
| 06 Mar, 2026 | Thane Wettig | Common Stock | D | 277 | $6.84 | 24,403 | D | F |
| 06 Mar, 2026 | Thane Wettig | Common Stock | D | 277 | $6.84 | 24,403 | D | F |
| 03 Feb, 2026 | David Delucia | Stock Option (Right to Buy) | A | 26,000 | $0.00 | 26,000 | D | A |
| 03 Feb, 2026 | Thane Wettig | Stock Option (Right to Buy) | A | 60,000 | $0.00 | 60,000 | D | A |
| 03 Feb, 2026 | Thane Wettig | Stock Option (Right to Buy) | A | 60,000 | $0.00 | 60,000 | D | A |
| 03 Feb, 2026 | Thane Wettig | Stock Option (Right to Buy) | A | 60,000 | $0.00 | 60,000 | D | A |
| 06 Dec, 2025 | Thane Wettig | Common Stock | D | 259 | $8.42 | 24,680 | D | F |
| 06 Dec, 2025 | Thane Wettig | Common Stock | D | 259 | $8.42 | 24,680 | D | F |
| 06 Dec, 2025 | Thane Wettig | Common Stock | D | 259 | $8.42 | 24,680 | D | F |
| 06 Dec, 2025 | David Delucia | Common Stock | D | 52 | $8.42 | 4,489 | D | F |
| 13 Nov, 2025 | Thane Wettig | Common Stock | A | 1,000 | $9.18 | 22,239 | D | P |
| 13 Nov, 2025 | Thane Wettig | Common Stock | A | 1,000 | $9.18 | 22,239 | D | P |
| 13 Nov, 2025 | Thane Wettig | Common Stock | A | 1,000 | $9.18 | 22,239 | D | P |
| 17 Nov, 2025 | Thane Wettig | Common Stock | A | 2,700 | $9.10 | 24,939 | D | P |
| 17 Nov, 2025 | Thane Wettig | Common Stock | A | 2,700 | $9.10 | 24,939 | D | P |
| 17 Nov, 2025 | Thane Wettig | Common Stock | A | 2,700 | $9.10 | 24,939 | D | P |
| 30 Jun, 2025 | James A Schoeneck | Common Stock | A | 23,567 | $5.07 | 39,666 | I | P |
| 30 Jun, 2025 | James A Schoeneck | Common Stock | A | 23,567 | $5.07 | 39,666 | I | P |